Get App Open
In App
Credit Cards
Open App
Loans

Mirae Asset Healthcare Fund - Direct plan - IDCW

  • Regular
  • Direct
Category : Sectoral/Thematic
  • NAV
    : ₹ 28.334 -0.45%
    (as on 07th November, 2025)
Crisil Rating

Not Rated

Rank not available for the fund
Risk-O-Meter
Very High Risk

The fund has 99.89% investment in domestic equities of which 34.74% is in Large Cap stocks, 20.24% is in Mid Cap stocks, 9.11% in Small Cap stocks.

Suitable For : Investors who have advanced knowledge of macro trends and prefer to take selective bets for higher returns compared to other Equity funds. At the same time, these investors should also be ready for possibility of moderate to high losses in their investments even though overall market is performing better.

This Scheme
VS
  • Benchmark
    BSE Healthcare TRI
  • NA
  • NA
  • Gold
Compare with
  • Date : -
  • NAV : -
  • Date : -
  • Investment : -
  • Value on selected date : -
  • Returns Calculator
  • SIP Calculator
  • VIP (Value Avg)
Amount
  • Investment Date
  • Sell Date
  • Investment Value
    -
  • Sell Value
    -
  • Profit/Loss
    -
  • Annualised Returns
    -
  • Date : -
  • Investment : -
  • Value on selected date : -

Returns (NAV as on 07th November, 2025)

Period Invested for ₹10000 Invested on Latest Value Absolute Returns Annualised Returns Category Avg Rank within Category
1 Week 31-Oct-25 9952.60 -0.47% - -0.79% 73/231
1 Month 07-Oct-25 10021.20 0.21% - 0.87% 151/227
3 Month 07-Aug-25 10147.20 1.47% - 3.98% 199/224
6 Month 07-May-25 10674.00 6.74% - 9.35% 148/213
YTD 01-Jan-25 9819.90 -1.80% - 4.42% 157/201
1 Year 07-Nov-24 10141.10 1.41% 1.41% 3.56% 118/187
2 Year 07-Nov-23 15325.50 53.25% 23.76% 20.54% 35/141
3 Year 07-Nov-22 18165.10 81.65% 21.99% 19.90% 37/117
5 Year 06-Nov-20 23750.50 137.50% 18.86% 22.81% 65/93
Since Inception 02-Jul-18 42746.10 327.46% 21.83% 13.90% 25/199

SIP Returns (NAV as on 07th November, 2025)

Period Invested for ₹1000 SIP Started on Investments Latest Value Absolute Returns Annualised Returns
1 Year 07-Nov-24 12000 12437.27 3.64 % 6.79 %
2 Year 07-Nov-23 24000 27366.31 14.03 % 13.14 %
3 Year 07-Nov-22 36000 48860.99 35.72 % 20.84 %
5 Year 06-Nov-20 60000 94970.11 58.28 % 18.4 %
 

Tax Treatment

If sold after 1 year from purchase date, long term capital gain tax will be applicable. Current tax rate is 12.5%, if your total long term capital gain exceeds 1.25 lakh. Any cess/surcharge is not included. If sold before 1 year from purchase date, short term capital gain tax will be applicable. Current tax rate is 20%. Any cess/surcharge is not included in the 20%.

Portfolio (Updated on 30th Sep,2025)

Portfolio Turnover Ratio : 34.00%  |   Category average turnover ratio is 203.09%  
Fund manager updated portfolio less frequently than peers in last 1 year. (I.e. fund manager held stocks/bonds in the portfolio for longer duration than peers)
Equity Holding : 99.89% | F&O Holdings : 0.00%| Foreign Equity Holdings : 0.00%| Total : 99.89%
No of Stocks : 30 (Category Avg - 44.42) | Large Cap Investments : 34.74%| Mid Cap Investments : 20.24% | Small Cap Investments : 9.11% | Other : 35.79%

Top 10 Stocks in Portfolio

How to read this table?
Stock Invested in Sector Value(Mn) % of Total Holdings 1M Change 1Y Highest Holding 1Y Lowest Holding Quantity 1M Change in Qty
Sun Pharmaceutical Industries Ltd. Pharmaceuticals 3195.6 11.57% 0.65% 12.5% (Apr 2025) 10.74% (Jul 2025) 20.04 L 90.00 k
Divis Laboratories Ltd. Pharmaceuticals 2143.1 7.76% -0.39% 8.53% (Jun 2025) 4.96% (Oct 2024) 3.77 L 5.00 k
Glenmark Pharmaceuticals Ltd. Pharmaceuticals 1925.5 6.97% 0.19% 7.24% (Jul 2025) 5.22% (Apr 2025) 9.86 L 0.00
Apollo Hospitals Enterprises Ltd. Hospital 1719.2 6.23% -0.09% 6.37% (Jun 2025) 4.82% (Dec 2024) 2.32 L 0.00
Cipla Ltd. Pharmaceuticals 1665.8 6.03% -0.27% 7.6% (Feb 2025) 6.03% (Sep 2025) 11.08 L 0.00
Lupin Ltd. Pharmaceuticals 1393.7 5.05% 0.10% 6.37% (Apr 2025) 4.94% (Jul 2025) 7.29 L 0.00
Aurobindo Pharma Ltd. Pharmaceuticals 1195.1 4.33% -1.69% 8.05% (Oct 2024) 4.33% (Sep 2025) 11.03 L -5.33 L
Dr. Reddys Laboratories Ltd. Pharmaceuticals 1158.2 4.19% -0.07% 6.38% (Dec 2024) 4.13% (Jul 2025) 9.46 L 0.00
Fortis Healthcare Ltd. Hospital 1157.1 4.19% 0.30% 4.19% (Sep 2025) 2.12% (Jan 2025) 11.93 L 0.00
Krishna Institute of Medical Sciences Ltd. Hospital 1033.2 3.74% -0.08% 4.32% (Nov 2024) 3.57% (Feb 2025) 14.76 L 0.00
- indicates change in weight in the portfolio. # indicates a new entry.
Name Type of Instrument Weight (%)
TREPS TREPS 0.25%
MF Units MF Units 0.01%
Net Receivables Net Receivables -0.15%

Risk Ratios

Ratios calculated on daily returns for last 3 years (Updated as on 31st October, 2025)

  • Standard Deviation

    Low volatility
    13.1vs13.95
    Category Avg
  • Beta

    Low volatility
    0.63vs0.86
    Category Avg
  • Sharpe Ratio

    Better risk adjusted returns
    1.05vs0.91
    Category Avg
  • Treynor's Ratio

    Better risk adjusted returns
    0.22vs0.17
    Category Avg
  • Jensen's Alpha

    Better risk adjusted returns
    8.53vs3.58
    Category Avg

Alternative Funds (Category Peers)

Scheme Name
Crisil Rank
Asset Size (Cr)
1M
3M
6M
1Y
3Y
Nippon India Taiwan Equity Fund - Direct Plan - Growth NA 406.67 1.56 18.80 61.31 42.13 41.29
Aditya Birla Sun Life International Equity Fund - Direct Plan - Growth NA 266.19 -1.72 3.82 18.65 26.30 17.89
Franklin Asian Equity Fund - Direct - Growth NA 279.13 1.42 10.85 23.53 20.70 16.64
Nippon India Japan Equity Fund - Direct Plan - Growth NA 289.73 -0.83 5.78 14.81 20.52 19.78
Quant BFSI Fund - Direct Plan - Growth NA 655.17 4.96 7.90 22.48 20.19 0.00
HDFC Transportation and Logistics Fund - Direct Plan - Growth NA 1651.55 -0.37 11.10 25.24 20.11 0.00
DSP Banking & Financial Services Fund - Direct Plan - Growth NA 1419.62 3.62 7.62 10.70 18.25 0.00
ITI Banking and Financial Services Fund - Direct Plan - Growth NA 311.03 4.60 7.67 9.73 17.83 15.60
SBI Banking & Financial Services Fund - Direct Plan - Growth NA 8693.07 2.90 6.11 11.70 16.53 20.38
Mirae Asset Banking and Financial Services Fund - Direct Plan - Growth NA 2014.27 3.68 5.76 10.24 14.98 18.89

More Funds from Mirae Asset Mutual Fund

Out of 51 mutual fund schemes offered by this AMC, 3 is/are ranked 5 * , 4 is/are ranked 4 * , 4 is/are ranked 3 * , 4 is/are ranked 2 * , and 36 schemes are not ranked. See more about AMC

Scheme Name
Crisil Rank
Asset Size (Cr)
1M
3M
6M
1Y
3Y
Mirae Asset Large & Midcap Fund - Direct Plan - Growth 3 40821.90 2.11 5.77 11.31 6.47 17.89
Mirae Asset Large Cap Fund - Direct Plan - Growth 3 39615.50 1.57 3.88 7.09 6.61 13.72
Mirae Asset ELSS Tax Saver Fund - Direct Plan - Growth 4 25910.64 2.00 5.05 9.91 7.35 18.10
Mirae Asset Midcap Fund - Direct Plan - Growth 3 17194.25 2.28 6.59 16.93 7.78 21.22
Mirae Asset Liquid Fund - Direct Plan - Growth 4 11367.77 0.48 1.46 3.05 6.76 7.09
Mirae Asset Aggressive Hybrid Fund - Direct Plan - Growth 3 9128.00 1.34 3.47 7.33 7.20 14.79
Mirae Asset Focused Fund - Direct Plan - Growth 2 7769.11 0.40 2.89 7.24 2.84 12.69
Mirae Asset Great Consumer Fund - Direct Plan - Growth NA 4632.32 -0.24 3.48 8.46 3.89 18.09
Mirae Asset Multicap Fund - Direct Plan - Growth NA 4126.15 1.29 4.53 11.97 6.30 0.00
Mirae Asset Flexi Cap Fund - Direct Plan - Growth NA 3107.47 2.48 5.05 11.26 8.30 0.00

Forum

+ See More

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347